NSG
MDT icon

Nalls Sherbakoff Group’s Medtronic MDT Stock Holding History

Nalls Sherbakoff Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-87
Closed -$7.54K – 408
2026
Q1 		$7.54K Hold
87
– – 0.01% 316
2025
Q4 		$8.36K Buy
+87
New +$8.45K 0.01% 337
2025
Q2 		– Sell
-31
Closed -$2.79K – 452
2025
Q1 		$2.79K Buy
+31
New +$2.77K ﹤0.01% 366
2023
Q2 		– Sell
-5
Closed -$396 – 510
2023
Q1 		$396 Buy
+5
New +$408 ﹤0.01% 489

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nalls Sherbakoff Group's MDT Position: Q2 2026 in Review

Nalls Sherbakoff Group sold out of Medtronic (MDT) in Q2 2026, closing a stake of 87 shares — an estimated $7.54K sold.

Nalls Sherbakoff Group first reported a position in MDT in Q1 2023 and held it in 4 quarters. The position peaked at $8.36K in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Nalls Sherbakoff Group reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Nalls Sherbakoff Group sold 87 Medtronic shares in Q2 2026, an estimated $7.54K.
  • Nalls Sherbakoff Group first reported a position in Medtronic in Q1 2023 and held it in 4 quarters.
  • Nalls Sherbakoff Group's Medtronic position peaked at $8.36K in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.